We and Mehtra showed that elevated CD133 mRNA levels in the peripheral blood mononuclear cells are associated with the progression and poor survival in colon cancer and other solid tumors [7], [10] To date, no study had been performed on the effects of treatment on circulating CD133 mRNA expression in patients with GIST. The gene discussed is PROM1; the disease is colonic neoplasm.